Cargando…
Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326927/ https://www.ncbi.nlm.nih.gov/pubmed/34349504 http://dx.doi.org/10.2147/PPA.S330289 |
Ejemplares similares
-
Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting
por: Senbel, Eric, et al.
Publicado: (2021) -
Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
por: Bianchi, Gerolamo, et al.
Publicado: (2016) -
Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis
por: Żuber, Zbigniew, et al.
Publicado: (2016) -
Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
por: Curtis, J. R., et al.
Publicado: (2016) -
Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register
por: Bechman, Katie, et al.
Publicado: (2020)